Investing Profile

Ken Sawyer

VCInvestorAngelFounder
Founder and Managing Director at Saints Capital
saintscapital.comUnited States
Photo of Ken Sawyer, Managing Director at Saints Capital
cb
Saints Capital Managing Director
$250K - $100.0M
$10.0M
16
$27.4M
CompanyStageDateRound SizeTotal Raised
Direct Flow Medical
Series CApr 2016$31M
$98M
Co-investors: Jeani Delagardelle (New Leaf Venture Partners), Renee Compton Ryan (Johnson & Johnson Innovation), Annette Bianchi (VantagePoint Capital Partners)
Siftery
SeedFeb 2016$4M
$4M
Co-investors: Jeremy Philips (Spark Capital), Chris Scoggins (SignalFire), Sam Lessin (Slow Ventures), Auren Hoffman (Flex Capital), Tod Sacerdoti (Flex Capital), Kevin Hartz (A* Capital (A Star Capital)), Jonah Goodhart (WGI Group), Patrick McKenna (Comeback Capital), Mitch Kitamura (DNX Ventures), Itamar Novick (Recursive Ventures), Michael Lazerow (Lazerow Ventures), Kevin Mahaffey (SNR), Eric Di Benedetto (quadratura.it), Julia Popowitz (Broadway Angels), Peter Kellner (Richmond Global Ventures), Russell Fradin, Mark Gerson, Jay Weintraub, Scott Faber, Ron Hirson, Ethan Beard, Eric Stein, Evangelos Simoudis, Eric Ries, Warren Jenson, Tien Tzuo, Brian O'Kelley, Kim Perell, Adam D'Angelo, Jeremy Lizt, Travis May, Joe Zawadzki, Joanna Rees, Charlie Songhurst, Russ Fradin
Fixt
SeedJan 2016$800K
$3.4M
Co-investors: Charles Hudson (Precursor Ventures), Alexander Bogusky (Batshit Crazy Ventures), Jonathan Weiner (Oak HC/FT), Joe Callanan (Blu Venture Investors), Chad Nitschke
Acsis
Series AApr 2015$250K
$250K
Gilt Groupe
Series FFeb 2015$50M
$270M
Co-investors: Randy Glein (DFJ), Henry Fertik (Strategic Beta), Dana Stalder (Matrix), Anton Levy (General Atlantic)
OrSense
Series HFeb 2015
Series HApr 2014
Debt FinancingJan 2014
Vidyo
Series EJul 2014$20M
Series DApr 2013$17M
$130M
Co-investors: Avery More (Menlo Ventures), Douglas Carlisle
Laureate Pharma
Debt FinancingOct 2010$20M
$20M
We provide liquidity for founders and investors for their private shares in great companies -usually mature enough to have meaningful revenue traction
Pre-revenue companies or shares in companies where the investors and founders are not supportive of a secondary transaction